Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06769997Recruiting
Comparing Optilume and Rezum for enlarged prostate
This study compares two treatments for an enlarged prostate: Optilume (a catheter-based system) and Rezum (water vapor therapy). It's for men with moderate symptoms who haven't tried other treatments before.
Montreal, QuebecAges 18 years+ - NCT06796686RecruitingPhase 1
HIV vaccine safety and immune response study for healthy adults
This trial tests a new two-part HIV vaccine regimen in healthy adults without HIV. The goal is to see if it is safe and produces an immune response that could help prevent HIV.
San Francisco, CaliforniaAges 18–55 - NCT06797401RecruitingPhase 2
RBD5044 for mixed high cholesterol and triglycerides
This trial tests a new medication called RBD5044 for people with mixed dyslipidemia (high levels of fats and cholesterol in the blood). It may help lower triglycerides and cholesterol when statins aren't enough.
LundAges 18–80 - NCT06801002RecruitingPhase 1
Safety trial of JBZ-001 for advanced cancers
This trial tests a new drug, JBZ-001, to see how safe it is for people with advanced solid tumors or certain types of lymphoma that have not improved with standard treatments. It's a first-in-human study, so participants will help doctors learn about the drug's side effects and the right dose.
Columbus, OhioAges 18 years+ - NCT06793215RecruitingPhase 3
Divarasib plus pembrolizumab for KRAS G12C lung cancer
This trial compares a new targeted drug (divarasib) combined with an immunotherapy (pembrolizumab) versus standard chemotherapy plus immunotherapy for people with advanced lung cancer that has a specific KRAS G12C mutation. It aims to see if the new combination works better and is safe.
Anchorage, AlaskaAges 18 years+ - NCT06797518RecruitingPhase 2
Testing iptacopan for IgA nephropathy kidney changes
This study tests if adding iptacopan to standard care can improve kidney health in adults with IgA nephropathy. You may qualify if you have a kidney biopsy confirming IgA nephropathy and your kidney function is stable enough.
Birmingham, AlabamaAges 18–99 - NCT06794541RecruitingPhase 2
Testing eravacycline for kids with serious belly infections
This trial tests an antibiotic called eravacycline for children (ages 8–17) with serious belly infections. The medicine is given through an IV in the hospital to see if it is safe and tolerable.
Los Angeles, CaliforniaAges 8–17 - NCT06793371RecruitingPhase 2
Study of CK-4021586 for heart failure with preserved ejection fraction
This trial tests an investigational drug called CK-4021586 for people with heart failure with preserved ejection fraction (HFpEF). It aims to see if the drug is safe and well-tolerated. You may qualify if you are 40 to 85, have heart failure symptoms, and have a heart that pumps well but shows signs of strain.
Fairhope, AlabamaAges 40–85 - NCT06795022RecruitingPhase 1/Phase 2
Testing AZD9793 for advanced solid tumors with GPC3
This trial is testing a new medicine, AZD9793, for people with advanced or metastatic solid tumors that have a specific marker called GPC3. The goal is to see if AZD9793 can help shrink or control the cancer.
La Jolla, CaliforniaAges 18 years+ - NCT06794697Recruiting
Does admission day affect anxiety before heart surgery?
This study looks at whether the day you are admitted to the hospital for planned heart surgery affects your anxiety levels before the operation. The goal is to help hospitals schedule admissions in a way that lowers stress for patients.
RennesAges 18 years+ - NCT06797245Recruiting
App-based treatment for overactive bladder in women
This trial tests a prescription digital app to help women with overactive bladder (OAB) symptoms. It may be a good fit if you are a woman over 22 with bothersome OAB and are willing to use the app instead of other treatments for 8 weeks.
Birmingham, AlabamaAges 22 years+ - NCT06797492Recruiting
Virtual Reality for Shoulder Problems
This trial tests whether virtual reality (a computer-made, 3D environment) can help people with shoulder problems recover better. You would use a VR headset for exercises, and the study will see if it improves your shoulder movement or pain.
Roma, ItalyAges 18–75 - NCT06792981Recruiting
Digital school program to prevent eating disorders in pre-teens
This trial tests a digital program for schools to help prevent eating disorders in pre-teens. It is designed for 5th and 6th graders and involves activities and questionnaires.
Santa Cruz de Tenerife, Santa Cruz de TenerifeAges 10–13 - NCT06797193Recruiting
Ultrasound technique to find liver blood pressure
This trial tests a new ultrasound technique called SHAPE to see if it can detect high blood pressure in the liver (portal hypertension) without needing an invasive procedure. It may help people who are already scheduled for a standard liver pressure measurement.
Scottsdale, ArizonaAges 18 years+ - NCT06794125Recruiting
Higher radiation dose for chest tumors
This trial tests if giving a higher dose of radiation to tumors in the chest (lungs or nearby areas) can better control symptoms or prevent them from getting worse. It is for people who need palliative radiation—treatment aimed at easing discomfort or slowing tumor growth, not curing the cancer.
Kelowna, British ColumbiaAges 18 years+ - NCT06801821Recruiting
Stigma study on skin conditions
This study looks at how people view those with certain skin conditions. It aims to understand stigma, which may help improve awareness and support.
Roma, ItaliaAges 18 years+ - NCT06800339RecruitingPhase 1
Immunotherapy and radiation before surgery for lung cancer
This trial tests combining chemotherapy, immunotherapy, and a low dose of radiation before surgery for people with non-small cell lung cancer that is borderline resectable (can potentially be removed but is close to nearby structures). It aims to see if this approach can shrink the tumor enough to allow successful surgery.
Baltimore, MarylandAges 18 years+ - NCT06795451RecruitingPhase 1/Phase 2
Spinal stimulation for depression: a clinical trial
This study tests if a non-invasive spinal stimulation device can improve depression symptoms. It is for people currently taking an antidepressant for at least 8 weeks but still experiencing depression.
Mason, OhioAges 18–60 - NCT06793059Recruiting
Flow diverter device for large brain aneurysms
This trial tests a new device called a flow diverter to treat large or giant brain aneurysms in a specific part of the internal carotid artery. The device is designed to block blood flow into the aneurysm and may help prevent rupture or other complications.
Buffalo, New YorkAges 22 years+ - NCT06801366Recruiting
Video clips to help diagnose sleep apnea in children
This study tests if video clips recorded at home can help diagnose obstructive sleep apnea in children, possibly reducing the need for an overnight hospital sleep test. It may be a good fit if your child is between 2 and 18 years old, has been referred for a sleep study, and you have a smartphone or tablet.
Edmonton, AlbertaAges 2–18 - NCT06801925Enrolling by invitation
Voice Chatbot for Depression Screening
This trial tests a voice chatbot that uses artificial intelligence to screen for depression. It aims to see if the chatbot is effective and easy to use.
LondonAges 18–65 - NCT06799481Recruiting
Home-based exercise to help brain tumor survivors with thinking and memory
This study tests whether a virtual home-based exercise program can improve thinking and memory problems caused by brain tumor treatment in teens and young adults. It also looks at how exercise affects gut health.
Atlanta, GeorgiaAges 15–39 - NCT06803147Recruiting
Stopping Surveillance for Low-Risk Barrett's Esophagus
This study is testing whether it's safe to stop regular surveillance endoscopies for people with low-risk Barrett's esophagus. If you have a short Barrett's segment without any dysplasia, you may be able to avoid future procedures.
AmsterdamAges Any age - NCT06803043Enrolling by invitation
Trauma-informed partner violence program for men
This trial tests a new kind of program for men who are required by the court to attend a partner violence intervention. The program is trauma-informed, which means it takes into account past experiences that might affect behavior. If you are a man on parole or probation in Rhode Island and have been ordered to attend an IPV (intimate partner violence) class, this study looks at how well the program works for you and your partner.
Boston, MassachusettsAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.